Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating
Published . Updated .
Fintel reports that on September 18, 2026, Leerink Partners initiated coverage of Entera Bio (NASDAQCM:ENTX) (DB:5DT) with a Outperform recommendation. This initiation represents the sole rating action recorded for the company on September 18, 2026, by Leerink Partners.Entera Bio
Directly affected
- ENTX Entera Bio
Named in this report.
Indirectly affected
- UPGD INVESCO BLOOMBERG ANALYST RATING ETF
GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 18, 2026, Leerink Partners initiated coverage of Entera Bio (NASDAQCM:ENTX) (DB:5DT) with a Outperform recommendation. This initiation represents the sole rating action recorded for the company on September…
Source: Nasdaq Markets
The price since 19 Sep 2026: Entera Bio (ENTX) versus the S&P 500
Since the first closing price after “Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating,” Entera Bio (ENTX) is -1.02%. The S&P 500 fund (SPY) is -0.89% over the same days, a -0.12% difference versus the market.
Who gains and who loses around Entera Bio (ENTX)
Companies carried with this story
- ENTX Entera Bio
Entera Bio (ENTX) is linked, with no stored direction, high confidence in the 19 Sep 2026 story “Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating.” Reason on file: The reported development directly names ENTERA BIO LTD in the headline; GA resolved that company to ENTX
- UPGD Invesco Bloomberg Analyst Rating Etf
Invesco Bloomberg Analyst Rating Etf (UPGD) is linked, with no stored direction, medium confidence in the 19 Sep 2026 story “Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating.” Reason on file: GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Entera Bio (ENTX)
The 19 Sep 2026 story “Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating” names Entera Bio (ENTX) because of this story.
The link for Entera Bio (ENTX) is this: The reported development directly names ENTERA BIO LTD in the headline; GA resolved that company to ENTX
Invesco Bloomberg Analyst Rating Etf (UPGD) is here too. Its reason reads: GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Entera Bio (ENTX) price range
ENTX traded between 2.44 and 3.03 across 20 sessions. The latest close on file is 2.92. UPGD traded between 80.14 and 82.00 across 17 sessions. The latest close on file is 82.00.
How strong the case is around Entera Bio (ENTX)
21 out of 100
“Leerink Partners Initiates Coverage of Entera Bio with Outperform Rating” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.